{"id":53504,"date":"2023-02-01T11:04:35","date_gmt":"2023-02-01T10:04:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-and-regional-next-generation-sequencing-ngs-informatics-market-report-2022-2032-burgeoning-opportunities-in-the-evolving-regulatory-landscape-for-clinical-ngs-researchandmarkets-com\/"},"modified":"2023-02-01T11:04:35","modified_gmt":"2023-02-01T10:04:35","slug":"global-and-regional-next-generation-sequencing-ngs-informatics-market-report-2022-2032-burgeoning-opportunities-in-the-evolving-regulatory-landscape-for-clinical-ngs-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-and-regional-next-generation-sequencing-ngs-informatics-market-report-2022-2032-burgeoning-opportunities-in-the-evolving-regulatory-landscape-for-clinical-ngs-researchandmarkets-com\/","title":{"rendered":"Global and Regional Next-Generation Sequencing (NGS) Informatics Market Report 2022-2032: Burgeoning Opportunities in the Evolving Regulatory Landscape for Clinical NGS – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “NGS Informatics Market – A Global and Regional Analysis: Focus on Products and Services, Application, End User, and Region – Analysis and Forecast, 2022-2032”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global NGS informatics market was valued at $1,380.0 million in 2021 and is projected to reach $6,715.0 million by the end of 2032. The market is expected to grow at a CAGR of 15.21% during the forecast period 2022-2032.\n<\/p>\n

\nThe market is driven by factors such as the low cost of sequencing platforms, increasing clinical applications of NGS in the field of oncology for the clinical management of cancer patients and mutation profiling, a tremendous rise in the amount of genomic data, the growing importance of population genomics studies and the establishment of various biobanks, advancements in big data technology, and government initiatives to support the advancement of NGS are expected to lead to higher demand for NGS informatics software.\n<\/p>\n

\nMarket Lifecycle Stage<\/strong>\n<\/p>\n

\nThe global NGS informatics market is in the development phase. The evolving regulatory landscape for clinical NGS and the growing number of gene mutations across various diseases are some of the major opportunities in the global NGS informatics market.\n<\/p>\n

\nImpact of COVID-19<\/strong>\n<\/p>\n

\nNGS can be used to sequence genomes of unknown organisms, owing to which it was extensively performed in research laboratories during the COVID-19 pandemic.\n<\/p>\n

\nResearch using NGS sequencing has been carried out in several countries globally, including countries in emerging regions such as Latin America and Middle East and Africa. Initiatives such as the “SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance (SPHERES)” program by the Centers for Disease Control and Prevention (CDC) were also undertaken to promote the sequencing of the SARS-CoV-2 virus using NGS techniques. Furthermore, the emergence of the COVID-19 pandemic broadened the applications of NGS.\n<\/p>\n

\nAs a result, companies also developed NGS solutions for the genomic surveillance of the SARS-CoV-2 virus. Before the COVID-19 pandemic, NGS technology was particularly employed for the clinical diagnosis of cancers and other chronic diseases. The onset of the COVID-19 pandemic accelerated research in the use of NGS for sequencing the unknown variants of the SARS-CoV-2 virus.\n<\/p>\n

\nMarket Segmentation<\/strong>\n<\/p>\n

\nProducts and Services: The global NGS informatics market (by products and services) is expected to be dominated by the commercial data analysis tools, interpretation, and reporting tools segment.\n<\/p>\n

\nApplication: The global NGS informatics market (by application) is expected to be dominated by the genetic screening segment.\n<\/p>\n

\nEnd User: The global NGS informatics market (by end user) is dominated by the pharmaceutical and biotechnology companies segment.\n<\/p>\n

\nRegion: The global NGS informatics market (by region) is dominated by the North America region.\n<\/p>\n

\nRecent Developments in the Global NGS Informatics Market<\/strong>\n<\/p>\n